Advances in Keratoconus Management - Summary - MDSpire

Advances in Keratoconus Management

Kendall Donaldson, MD, discusses how crosslinking innovation and collaborative care are improving outcomes for patients.

  • May 1, 2026

  • 4 min

Share

Objective:

To highlight the advancements in keratoconus treatment, particularly through corneal crosslinking technology, and its significance in transforming patient care.

Key Findings:
  • Corneal crosslinking has significantly reduced the need for full-thickness corneal transplants, with a noted decrease in transplant rates.
  • Epi-on crosslinking has been recently approved, offering a less invasive option for patients, potentially increasing treatment uptake.
  • Visual rehabilitation techniques, such as CTAK, are improving patient comfort and outcomes, with specific patient feedback or case studies.
Interpretation:

The advancements in keratoconus management, particularly through crosslinking, are transforming patient care and outcomes, allowing for earlier intervention and better visual rehabilitation, which is crucial for long-term patient satisfaction.

Limitations:
  • Currently, only 15% to 20% of keratoconus patients who are candidates for crosslinking are receiving treatment, highlighting a significant gap in care.
  • Ongoing need for improved identification and collaboration to increase treatment rates, including addressing patient awareness and access to care.
Conclusion:

The future of keratoconus management looks promising with ongoing innovations and a focus on early detection and collaborative care, emphasizing the need for continued efforts to increase treatment accessibility.

Original Source(s)

Advances in Keratoconus Management

  • May 1, 2026

Related Content

Keratoconus Care Continues to Evolve

Susan Gromacki, OD, MS, FAAO, FSLS, Dipl AAO, and Clark Chang, OD, FAAO, FSLS, reviewed the latest developments in diagnosis, imaging, contact lenses, corneal cross-linking (CXL), and surgical management for KC.

Keratoconus in Hormonal Flux 

Is it time to rethink the importance of hormonal changes on keratoconus pathology?

  • February 12, 2026

  • 3 min
The 25-Year Odyssey of the Global Specialty Lens Symposium 

In their keynote address to the 2026 Global Specialty Lens Symposium, Craig W. Norman and Patrick J. Caroline recounted the evolution of the event over the past 2+ decades.